Showing results (81-90 of 215) with videos related to
Sort By:
Pageof 22
Journal of Neurovirology|August 20, 2025
Changes in cerebral function parameters in persons with HIV with symptoms of insomnia switching from dolutegravir- to bictegravir-based antiretroviral therapyMerle Henderson, Kate Alford, Samira Bouyagoub, et al.HIV Clinical Trials|March 18, 2015
The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of ageJaime H Vera, Akil Jackson, Laura Dickinson, et al.AIDS (London, England)|April 20, 2004
Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?Alan Winston, Anton Pozniak, Nicola Smith, et al.Statistics in Medicine|November 29, 2016
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatmentAlexina J Mason, Juan Gonzalez-Maffe, Killian Quinn, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsAnna Jane Dreyer, Celine Le Roux, Kevin G F Thomas, et al.The Journal of Infectious Diseases|July 9, 2018
Chronic Kidney Disease Risk in African and Caribbean Populations With HIVSophie Jose, Lisa Hamzah, Rachael Jones, et al.AIDS (London, England)|June 19, 2018
Clinical research cerebral MRI findings in HIV-positive subjects and appropriate controlsSrishti Chhabra, Jonathan Underwood, James H Cole, et al.The Lancet. HIV|September 26, 2025
Understanding and managing disordered sleep in people with HIVLuxsena Sukumaran, Karine Scheuermaier, Caroline A Sabin, et al.The Journal of Antimicrobial Chemotherapy|July 6, 2005
Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapyAlan Winston, Mark Bloch, Andrew Carr, et al.AIDS (London, England)|June 23, 2006
Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteersAlan Winston, David Back, Carl Fletcher, et al.Pageof 22